TY - JOUR
T1 - Generalized and Naevoid Epidermolytic Ichthyosis in Denmark
T2 - Clinical and Mutational Findings
AU - Bygum, Anette
AU - Virtanen, Marie
AU - Brandrup, Flemming
AU - Gånemo, Agneta
AU - Sommerlund, Mette
AU - Strauss, Gitte
AU - Vahlquist, Anders
N1 - Epub ahead of print
PY - 2013/3
Y1 - 2013/3
N2 - A Danish-Swedish collaboration was established to identify and classify a Danish cohort of patients with epidermolytic ichthyosis, also known as epidermolytic hyperkeratosis. Patients were recruited from 5 dermatology departments in Denmark, and data were obtained using a structured questionnaire and a systematic examination together with photographs, histopathological descriptions and blood samples for mutational analysis. Sixteen patients from 12 families with generalized or naevoid epidermolytic ichthyosis and ichthyosis bullosa of Siemens were identifed. Five families had mutations in K1 and 6 families had mutations in K10. Nine patients had been treated with systemic retinoids (etretinate, aci-tretin, isotretinoin or alitretinoin), but only 3 patients had acceptable treatment responses and chose to continue therapy. In conclusion epidermolytic ichthyosis is a rare disease with a prevalence of approximately 1 in 350,000 in Denmark and a high percentage of de novo mutations (75%). We identifed 4 novel disease-causing mutations.
AB - A Danish-Swedish collaboration was established to identify and classify a Danish cohort of patients with epidermolytic ichthyosis, also known as epidermolytic hyperkeratosis. Patients were recruited from 5 dermatology departments in Denmark, and data were obtained using a structured questionnaire and a systematic examination together with photographs, histopathological descriptions and blood samples for mutational analysis. Sixteen patients from 12 families with generalized or naevoid epidermolytic ichthyosis and ichthyosis bullosa of Siemens were identifed. Five families had mutations in K1 and 6 families had mutations in K10. Nine patients had been treated with systemic retinoids (etretinate, aci-tretin, isotretinoin or alitretinoin), but only 3 patients had acceptable treatment responses and chose to continue therapy. In conclusion epidermolytic ichthyosis is a rare disease with a prevalence of approximately 1 in 350,000 in Denmark and a high percentage of de novo mutations (75%). We identifed 4 novel disease-causing mutations.
KW - Epider-molytic ichthy osis
KW - Epidermolytic hyperkeratosis
KW - Genomic DNA sequencing
KW - Phenoty-pic variation
U2 - 10.2340/00015555-1447
DO - 10.2340/00015555-1447
M3 - Journal article
C2 - 22930352
SN - 0001-5555
VL - 93
SP - 309
EP - 313
JO - Acta Dermato-Venereologica
JF - Acta Dermato-Venereologica
IS - 3
ER -